"Professor Wipat's lab at Newcastle is producing some of themost important research in synthetic biology today, and we are excited to becollaborating with him," said Dr. Jeremy Minshull, cofounder and CEO of DNA2.0,in a press release. "By combining our patented GeneGPS technology—which hasbeen proven to increase protein expression up to 100-fold—with Newcastle's deepexperience with
B. subtillis, I'mconfident that we will develop a best-in-class solution for this importantbacterium for industrial biotechnology."
In addition to developing a robust expression system for B.subtillis, the two organizations expect that the gene design algorithms thatthey develop will be likely to mimic related gram positives that are also verypopular in industrial biotechnology. Industrially important organisms such as Clostridium,Lactobacillus and Geobacillus share similarities with B. subtilis in their development and genetics. As a result, theknowledge gained from optimizing expression for this organism promises to bemore widely applicable in an industrial context, according to the partners.